Related references
Note: Only part of the references are listed.Multidomain Control Over TEC Kinase Activation State Tunes the T Cell Response
Amy H. Andreotti et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 36 (2018)
Advances in understanding the pathogenesis of acquired aplastic anaemia
Lucio Luzzatto et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Phosphorylation-Mediated IFN-gamma R2 Membrane Translocation Is Required to Activate Macrophage Innate Response
Xiaoqing Xu et al.
CELL (2018)
Ibrutinib treatment improves T cell number and function in CLL patients
Meixiao Long et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Bruton's Tyrosine Kinase: An Emerging Key Player in Innate Immunity
Alexander N. R. Weber et al.
FRONTIERS IN IMMUNOLOGY (2017)
Bruton's tyrosine kinase (BTK) as a promising target in solid tumors
J. Molina-Cerrillo et al.
CANCER TREATMENT REVIEWS (2017)
Myeloid-Derived Suppressor Cells Express Bruton's Tyrosine Kinase and Can Be Depleted in Tumor-Bearing Hosts by Ibrutinib Treatment
Andrew Stiff et al.
CANCER RESEARCH (2016)
The Neutrophil Btk Signalosome Regulates Integrin Activation during Sterile Inflammation
Stephanie Volmering et al.
IMMUNITY (2016)
Acalabrutinib (ACP-196): a selective second-generation BTK inhibitor
Jingjing Wu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
Graded Foxo1 activity in Treg cells differentiates tumour immunity from spontaneous autoimmunity
Chong T. Luo et al.
NATURE (2016)
Itk is required for Th9 differentiation via TCR-mediated induction of IL-2 and IRF4
Julio Gomez-Rodriguez et al.
NATURE COMMUNICATIONS (2016)
CXCR4 expression on pathogenic T cells facilitates their bone marrow infiltration in a mouse model of aplastic anemia
Christina Arieta Kuksin et al.
BLOOD (2015)
FDA Approval: Ibrutinib for Patients with Previously Treated Mantle Cell Lymphoma and Previously Treated Chronic Lymphocytic Leukemia
R. Angelo de Claro et al.
CLINICAL CANCER RESEARCH (2015)
Inhibition of BTK and ITK with Ibrutinib Is Effective in the Prevention of Chronic Graft-versus-Host Disease in Mice
Steven D. Schutt et al.
PLOS ONE (2015)
Bruton's Tyrosine Kinase Phosphorylates DDX41 and Activates Its Binding of dsDNA and STING to Initiate Type 1 Interferon Response
Koon-Guan Lee et al.
CELL REPORTS (2015)
IFN-γ causes aplastic anemia by altering hematopoietic stem/progenitor cell composition and disrupting lineage differentiation
Fan-ching Lin et al.
BLOOD (2014)
Ibrutinib treatment ameliorates murine chronic graft-versus-host disease
Jason A. Dubovsky et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Ezh2 Regulates Transcriptional and Posttranslational Expression of T-bet and Promotes Th1 Cell Responses Mediating Aplastic Anemia in Mice
Qing Tong et al.
JOURNAL OF IMMUNOLOGY (2014)
Targeting Bruton's tyrosine kinase in B cell malignancies
Rudi W. Hendriks et al.
NATURE REVIEWS CANCER (2014)
Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes
Jason A. Dubovsky et al.
BLOOD (2013)
Therapeutic targeting of NOTCH signaling ameliorates immune-mediated bone marrow failure of aplastic anemia
Justine E. Roderick et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Current concepts in the pathophysiology and treatment of aplastic anemia
Neal S. Young
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2013)
Intrinsic impairment of CD4+CD25+ regulatory T cells in acquired aplastic anemia
Jun Shi et al.
BLOOD (2012)
Tyrosine Kinase Btk Is Required for NK Cell Activation
Yan Bao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Bruton's tyrosine kinase phosphorylates Toll-like receptor 3 to initiate antiviral response
Koon-Guan Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Notch signaling is a critical regulator of allogeneic CD4+ T-cell responses mediating graft-versus-host disease
Yi Zhang et al.
BLOOD (2011)
The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-γ
Feng Ma et al.
NATURE IMMUNOLOGY (2011)
Intracellular MHC class II molecules promote TLR-triggered innate immune responses by maintaining activation of the kinase Btk
Xingguang Liu et al.
NATURE IMMUNOLOGY (2011)
Clinical management of aplastic anemia
Amy E. DeZern et al.
EXPERT REVIEW OF HEMATOLOGY (2011)
The role of the Th1 transcription factor T-bet in a mouse model of immune-mediated bone-marrow failure
Yong Tang et al.
BLOOD (2010)
Correlation of mRNA and protein levels: Cell type-specific gene expression of cluster designation antigens in the prostate
Laura E. Pascal et al.
BMC GENOMICS (2008)
Tyrosine kinases Btk and Tec regulate osteoclast differentiation by linking RANK and ITAM signals
Masahiro Shinohara et al.
CELL (2008)
Identification of novel regulators in T-cell differentiation of aplastic anemia patients
Anke Franzke et al.
BMC GENOMICS (2006)
MyD88 adapter-like (Mal) is phosphorylated by Bruton's tyrosine kinase during TLR2 and TLR4 signal transduction
P Gray et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Immune pathophysiology of aplastic anemia
S Nakao et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2005)
Expression and function of Tec, Itk, and Btk in lymphocytes: Evidence for a unique role for Tec
MG Tomlinson et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
A mouse model of lymphocyte infusion-induced bone marrow failure
ML Bloom et al.
EXPERIMENTAL HEMATOLOGY (2004)
New insights into the regulation and functions of Tec family tyrosine kinases in the immune system
AT Miller et al.
CURRENT OPINION IN IMMUNOLOGY (2002)
The cellular phenotype conditions Btk for cell survival or apoptosis signaling
TC Islam et al.
IMMUNOLOGICAL REVIEWS (2000)
Share Paper
